// App-Quantinova.ai

: Impact of Prolonging CMV Prophylaxis in High-Risk (CMV D+/R-) Lung Transplant Recipients

Researchers

Presenter

  • S. Herrera

Principal Investigators

  • B. Khan

  • S. Husain

  • M. Binnie

  • C. Chow

  • T. Martinu

  • C. Chaparro

  • S. Keshavjee

  • L.G. Singer

  • J. Tikkanen

Medical Centers

  • Multi Organ Transplant Unit, Division of Infectious Diseases, University Health Network, Toronto, ON, Canada

  • and Toronto Lung Transplant Program, University Health Network, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Cytomegalovirus infection

Biomarkers

  • N/A

Drug/Treatment

  • TA-9070

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved